{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:53:23Z","timestamp":1792367603618,"version":"4.4.0"},"reference-count":86,"publisher":"Portland Press Ltd.","issue":"2","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,2,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Triple-negative breast cancer (TNBC) is the most malignant and fatal subtype of breast cancer, which has characterized by negativity expression of ER, PR, and HER2. Metastasis is the main factor affecting the prognosis of TNBC, and the process of metastasis is related to abnormal activation of epithelial\u2013mesenchymal transition (EMT). Recent studies have shown that long non-coding RNA (LncRNA) plays an important role in regulating the metastasis and invasion of TNBC. Therefore, based on the metastasis-related EMT signaling pathway, great efforts have confirmed that LncRNA is involved in the molecular mechanism of TNBC metastasis, which will provide new strategies to improve the treatment and prognosis of TNBC. In this review, we summarized many signal pathways related to EMT involved in the transfer process. The advances from the most recent studies of lncRNAs in the EMT-related signal pathways of TNBC metastasis. We also discussed the clinical research, application, and challenges of LncRNA in TNBC.<\/jats:p>","DOI":"10.1042\/bsr20203121","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T15:29:34Z","timestamp":1610638174000},"update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis"],"prefix":"10.1042","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-0430","authenticated-orcid":false,"given":"Haomeng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Xi\u2019an No. 3 Hospital, The Affiliated Hospital of Northwest University, Fengcheng 3rd Road 10, Weiyang District, Xi\u2019an, Shaanxi 710018, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, The First Affiliated Hospital of Xi'an Jiaotong University, Yanta West Road 277, Yanta District, Xi\u2019an, Shaanxi 710061, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Xi\u2019an No. 3 Hospital, The Affiliated Hospital of Northwest University, Fengcheng 3rd Road 10, Weiyang District, Xi\u2019an, Shaanxi 710018, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjie","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Xi\u2019an No. 3 Hospital, The Affiliated Hospital of Northwest University, Fengcheng 3rd Road 10, Weiyang District, Xi\u2019an, Shaanxi 710018, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery, Xi\u2019an No. 3 Hospital, The Affiliated Hospital of Northwest University, Fengcheng 3rd Road 10, Weiyang District, Xi\u2019an, Shaanxi 710018, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"2021111620382906900_B1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3322\/caac.21412","article-title":"Breast cancer statistics, 2017, racial disparity in mortality by state","volume":"67","author":"Desantis","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"2021111620382906900_B2","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/cancers11111802","article-title":"Long Non-Coding RNA: Dual Effects on Breast Cancer Metastasis and Clinical Applications","volume":"11","author":"Huang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2021111620382906900_B3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3233\/BD-2010-0319","article-title":"Epidemiology of triple negative breast cancers","volume":"32","author":"Gierach","year":"2010","journal-title":"Breast Dis."},{"key":"2021111620382906900_B4","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/jcmm.13327","article-title":"Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers","volume":"22","author":"Kong","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"2021111620382906900_B5","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1136\/esmoopen-2018-000357","article-title":"How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies","volume":"3","author":"Park","year":"2018","journal-title":"ESMO Open"},{"key":"2021111620382906900_B6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional Classification and Experimental Dissection of Long Noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"2021111620382906900_B7","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long Noncoding RNA and Cancer: A New Paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"2021111620382906900_B8","doi-asserted-by":"publisher","first-page":"28176","DOI":"10.18632\/oncotarget.14945","article-title":"Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"2021111620382906900_B9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ctrv.2017.10.014","article-title":"Triple negative breast cancer in Asia: An insider's view","volume":"62","author":"Wang","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"2021111620382906900_B10","doi-asserted-by":"publisher","first-page":"e1000279","DOI":"10.1371\/journal.pmed.1000279","article-title":"Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies","volume":"7","author":"Blows","year":"2010","journal-title":"PLoS Med."},{"key":"2021111620382906900_B11","first-page":"216","article-title":"Context-dependent EMT programs in cancer metastasis","author":"Aiello","year":"2019","journal-title":"J. Exp. Med."},{"key":"2021111620382906900_B12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/jcm5070065","article-title":"EMT in Breast Carcinoma-A Review","volume":"5","author":"Felipe","year":"2016","journal-title":"J. Clin. Med."},{"key":"2021111620382906900_B13","first-page":"11","article-title":"New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer","author":"Khaled","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2021111620382906900_B14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fonc.2019.00407","article-title":"The Role of lncRNAs in the Distant Metastasis of Breast Cancer","volume":"9","author":"Wu","year":"2019","journal-title":"Front. Oncol."},{"key":"2021111620382906900_B15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/cancers11020216","article-title":"New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis","volume":"11","author":"Sun","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2021111620382906900_B16","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1016\/j.ejca.2009.06.027","article-title":"Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases","volume":"45","author":"Heitz","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"2021111620382906900_B17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT Transition States during Tumor Progression and Metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol."},{"key":"2021111620382906900_B18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1083\/jcb.201103097","article-title":"A p53\/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition","volume":"195","author":"Kim","year":"2011","journal-title":"J. Cell Biol."},{"key":"2021111620382906900_B19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/1756-0500-6-470","article-title":"A useful method of identifying of miRNAs which can down-regulate Zeb-2","volume":"6","author":"Oba","year":"2013","journal-title":"BMC Res. Notes"},{"key":"2021111620382906900_B20","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"2021111620382906900_B21","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1084\/jem.20071082","article-title":"Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin","volume":"204","author":"Leong","year":"2007","journal-title":"J. Exp. Med."},{"key":"2021111620382906900_B22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fgene.2015.00002","article-title":"Non-coding RNA: what is functional and what is junk?","volume":"6","author":"Palazzo","year":"2015","journal-title":"Front. Genet."},{"key":"2021111620382906900_B23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.117.311802","article-title":"Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function","volume":"122","author":"Sallam","year":"2018","journal-title":"Circ. Res."},{"key":"2021111620382906900_B24","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"2021111620382906900_B25","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncRNAs in cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat. Med."},{"key":"2021111620382906900_B26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/bfgp\/elv049","article-title":"Long noncoding RNAs in regulation of human breast cancer","volume":"15","author":"Wang","year":"2016","journal-title":"Brief. Funct. Genomics"},{"key":"2021111620382906900_B27","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/jcp.25830","article-title":"Long noncoding RNAs (lncRNAs) in triple negative breast cancer","volume":"232","author":"Wang","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"2021111620382906900_B28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/cancers11030363","article-title":"Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity","volume":"11","author":"Gupta","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2021111620382906900_B29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12935-018-0674-0","article-title":"Research progresses in roles of LncRNA and its relationships with breast cancer","volume":"18","author":"Bin","year":"2018","journal-title":"Cancer Cell Int."},{"key":"2021111620382906900_B30","doi-asserted-by":"publisher","first-page":"e1600220","DOI":"10.1126\/sciadv.1600220","article-title":"Portraying breast cancers with long noncoding RNAs","volume":"2","author":"Van Grembergen","year":"2016","journal-title":"Sci. Adv."},{"key":"2021111620382906900_B31","doi-asserted-by":"publisher","first-page":"13047","DOI":"10.18632\/oncotarget.7509","article-title":"LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer","volume":"7","author":"Lv","year":"2016","journal-title":"Oncotarget"},{"key":"2021111620382906900_B32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.gene.2016.07.002","article-title":"Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer","volume":"591","author":"Yang","year":"2016","journal-title":"Gene"},{"key":"2021111620382906900_B33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/cge.13502","article-title":"Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?","volume":"95","author":"Mathias","year":"2019","journal-title":"Clin. Genet."},{"key":"2021111620382906900_B34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.biopha.2018.05.056","article-title":"Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p","volume":"104","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"2021111620382906900_B35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-3-319-91442-8_8","article-title":"Everolimus","volume":"211","author":"Hasskarl","year":"2018","journal-title":"Recent Results Cancer Res."},{"key":"2021111620382906900_B36","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/bcr3634","article-title":"Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer","volume":"16","author":"Singh","year":"2014","journal-title":"Breast Cancer Res."},{"key":"2021111620382906900_B37","doi-asserted-by":"publisher","first-page":"1078111537","DOI":"10.1177\/1533033819843889","article-title":"Long Non-Coding RNA and Breast Cancer","volume":"18","author":"Zhang","year":"2019","journal-title":"Technol. Cancer Res. Treat."},{"key":"2021111620382906900_B38","doi-asserted-by":"publisher","first-page":"8707053","DOI":"10.1155\/2019\/8707053","article-title":"Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype","volume":"2019","author":"Giuli","year":"2019","journal-title":"J. Oncol."},{"key":"2021111620382906900_B39","doi-asserted-by":"publisher","first-page":"e12342","DOI":"10.1111\/cpr.12342","article-title":"CCAT2: A novel oncogenic long non-coding RNA in human cancers","volume":"50","author":"Xin","year":"2017","journal-title":"Cell Prolif."},{"key":"2021111620382906900_B40","doi-asserted-by":"publisher","first-page":"104628","DOI":"10.1016\/j.phrs.2020.104628","article-title":"Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells","volume":"152","author":"Xu","year":"2020","journal-title":"Pharmacol. Res."},{"key":"2021111620382906900_B41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.biopha.2017.12.031","article-title":"Long non-coding RNA OIP5-AS1 functions as an oncogene in lung adenocarcinoma through targeting miR-448\/Bcl-2","volume":"98","author":"Deng","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"2021111620382906900_B42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12935-020-01234-7","article-title":"Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression","volume":"20","author":"Wang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"2021111620382906900_B43","first-page":"103","article-title":"Linc-OIP5 loss regulates migration and invasion in MDA-MB-231 breast cancer cells by inhibiting YAP1\/JAG1 signaling","volume":"19","author":"Zhu","year":"2020","journal-title":"Oncol. Lett."},{"key":"2021111620382906900_B44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/labinvest.2017.29","article-title":"The Hippo signaling functions through the Notch signaling to regulate intrahepatic bile duct development in mammals","volume":"97","author":"Wu","year":"2017","journal-title":"Lab. Invest."},{"key":"2021111620382906900_B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40659-020-0273-0","article-title":"Linc-OIP5 in the breast cancer cells regulates angiogenesis of human umbilical vein endothelial cells through YAP1\/Notch\/NRP1 signaling circuit at a tumor microenvironment","volume":"53","author":"Zhu","year":"2020","journal-title":"Biol. Res."},{"key":"2021111620382906900_B46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.stem.2010.03.020","article-title":"Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture","volume":"6","author":"Zeng","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2021111620382906900_B47","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1094291","article-title":"Convergence of Wnt, beta-catenin, and cadherin pathways","volume":"303","author":"Nelson","year":"2004","journal-title":"Science"},{"key":"2021111620382906900_B48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jcb.23350","article-title":"The Wnt\/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer","volume":"113","author":"King","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"2021111620382906900_B49","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3389\/fphar.2020.01107","article-title":"Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt\/beta-Catenin Signaling Pathway in Triple-Negative Breast Cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"2021111620382906900_B50","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1139\/bcb-2018-0313","article-title":"The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-beta-catenin signaling pathway","volume":"97","author":"Han","year":"2019","journal-title":"Biochem. Cell Biol."},{"key":"2021111620382906900_B51","first-page":"599","article-title":"Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt\/beta-catenin\/mTOR\/PI3K signaling","volume":"72","author":"Liu","year":"2017","journal-title":"Pharmazie"},{"key":"2021111620382906900_B52","first-page":"2819","article-title":"LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt\/beta-catenin signaling pathway","volume":"20","author":"Xiao","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"2021111620382906900_B53","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature07275","article-title":"A paracrine requirement for hedgehog signalling in cancer","volume":"455","author":"Yauch","year":"2008","journal-title":"Nature"},{"key":"2021111620382906900_B54","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-10-2711","article-title":"Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF","volume":"71","author":"Lai","year":"2011","journal-title":"Cancer Res."},{"key":"2021111620382906900_B55","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/15476286.2015.1053687","article-title":"LncRNA BCAR4 wires up signaling transduction in breast cancer","volume":"12","author":"Xing","year":"2015","journal-title":"RNA Biol."},{"key":"2021111620382906900_B56","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/2211-5463.12833","article-title":"LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway","volume":"10","author":"Qiu","year":"2020","journal-title":"FEBS Open Bio."},{"key":"2021111620382906900_B57","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1159\/000491980","article-title":"LOC101930370\/MiR-1471 Axis Modulates the Hedgehog Signaling Pathway in Breast Cancer","volume":"48","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"2021111620382906900_B58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jclinpath-2012-201361","article-title":"Therapeutic targets in triple negative breast cancer","volume":"66","author":"O'Toole","year":"2013","journal-title":"J. Clin. Pathol."},{"key":"2021111620382906900_B59","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/j.1349-7006.2012.02359.x","article-title":"Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells","volume":"103","author":"Yunokawa","year":"2012","journal-title":"Cancer Sci."},{"key":"2021111620382906900_B60","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1111\/jcmm.14213","article-title":"Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"2021111620382906900_B61","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1242\/bio.023135","article-title":"Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression","volume":"6","author":"Sha","year":"2017","journal-title":"Biol Open"},{"key":"2021111620382906900_B62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2017.06.009","article-title":"lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition","volume":"405","author":"Jiang","year":"2017","journal-title":"Cancer Lett."},{"key":"2021111620382906900_B63","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41419-018-1220-7","article-title":"LncRNA DANCR upregulates PI3K\/AKT signaling through activating serine phosphorylation of RXRA","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"key":"2021111620382906900_B64","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.biopha.2018.05.056","article-title":"Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p","volume":"104","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"2021111620382906900_B65","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/jcp.27066","article-title":"Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K\/Akt\/mTOR signaling pathway","volume":"234","author":"Lu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"2021111620382906900_B66","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2001-1326-3-23","article-title":"Biomechanics of TGFbeta-induced epithelial-mesenchymal transition: implications for fibrosis and cancer","volume":"3","author":"O'Connor","year":"2014","journal-title":"Clin. Transl. Med."},{"key":"2021111620382906900_B67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1124\/jpet.116.234799","article-title":"The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor beta1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-beta1 and Suppresses Tumor Metastasis","volume":"359","author":"Zhou","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021111620382906900_B68","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1186\/s12885-019-6264-2","article-title":"LncRNA WT1-AS up-regulates p53 to inhibit the proliferation of cervical squamous carcinoma cells","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"key":"2021111620382906900_B69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbadis.2015.10.001","article-title":"Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer","volume":"1862","author":"Du","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"2021111620382906900_B70","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/cbr.2019.2925","article-title":"LncRNA WT1-AS Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Downregulating Transforming Growth Factor beta1","volume":"34","author":"Wang","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"key":"2021111620382906900_B71","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1002\/cam4.2335","article-title":"LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"2021111620382906900_B72","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.1158\/0008-5472.CAN-04-1918","article-title":"Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice","volume":"64","author":"Schimmer","year":"2004","journal-title":"Cancer Res."},{"key":"2021111620382906900_B73","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.18632\/aging.102080","article-title":"CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218\/ZFX signaling","volume":"11","author":"Han","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"2021111620382906900_B74","doi-asserted-by":"publisher","first-page":"13303","DOI":"10.1002\/jcp.28007","article-title":"Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p\/HOXC6 signaling pathway","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"2021111620382906900_B75","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tips.2012.01.005","article-title":"Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy","volume":"33","author":"Semenza","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"2021111620382906900_B76","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"2021111620382906900_B77","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb3295","article-title":"The LINK-A lncRNA activates normoxic HIF1alpha signalling in triple-negative breast cancer","volume":"18","author":"Lin","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"2021111620382906900_B78","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.1038\/s41388-018-0396-8","article-title":"LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer","volume":"37","author":"Luo","year":"2018","journal-title":"Oncogene"},{"key":"2021111620382906900_B79","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.drudis.2017.01.013","article-title":"Safety of antisense oligonucleotide and siRNA-based therapeutics","volume":"22","author":"Chi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"2021111620382906900_B80","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1177\/0192623316645860","article-title":"Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy","volume":"44","author":"Ramot","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"2021111620382906900_B81","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"2021111620382906900_B82","doi-asserted-by":"publisher","first-page":"30177","DOI":"10.1016\/j.semcancer.2019.10.020","article-title":"Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges","volume":"S1044-579X","author":"Mirza","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"2021111620382906900_B83","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2017.12.022","article-title":"Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model","volume":"271","author":"Alshaer","year":"2018","journal-title":"J. Control. Release"},{"key":"2021111620382906900_B84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jconrel.2014.07.001","article-title":"Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles","volume":"192","author":"Liu","year":"2014","journal-title":"J. Control. Release"},{"key":"2021111620382906900_B85","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1021\/acs.bioconjchem.9b00028","article-title":"Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy","volume":"30","author":"Vaidya","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"2021111620382906900_B86","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13148-018-0514-z","article-title":"Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer","volume":"10","author":"Rodriguez","year":"2018","journal-title":"Clin. Epigenetics"}],"container-title":["Bioscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20203121\/903389\/bsr-2020-3121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/bioscirep\/article-pdf\/doi\/10.1042\/BSR20203121\/903389\/bsr-2020-3121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T17:43:19Z","timestamp":1697564599000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/bioscirep\/article\/41\/2\/BSR20203121\/227597\/The-role-of-EMT-related-lncRNA-in-the-process-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,26]]}},"URL":"https:\/\/doi.org\/10.1042\/bsr20203121","relation":{},"ISSN":["0144-8463","1573-4935"],"issn-type":[{"value":"0144-8463","type":"print"},{"value":"1573-4935","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2]]},"published":{"date-parts":[[2021,2]]},"article-number":"BSR20203121"}}